Dr Crystal L Mackall must be listening to Dr Jedd Wolchok
.... Her group was one of the first to demonstrate the success of a cancer therapy for pediatric acute lymphoblastic leukemia that works by modifying the patient’s own immune cells. The cells are removed from the patient, engineered to express cancer-specific receptors and returned to the patient, where they attack the cancer.
We have entered the golden age of immunotherapy for cancer. Mackall also serves as co-leader of Stand Up 2 Cancer’s Pediatric Cancer Dream Team, a multi-institutional program focused on developing novel immunotherapies for childhood cancer. She holds patents or has patents pending for nine advances in cancer immune therapy.